Sivik Global Healthcare’s Eli Lilly LLY Stock Holding History

Sivik Global Healthcare’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.6M	Hold	5,000	–	–	3.49%	7
2026 Q1	$4.6M	Sell	5,000 -2,000	-29%	-$2.03M	3.49%	7
2025 Q4	$7.52M	Sell	7,000 -3,000	-30%	-$2.87M	2.18%	10
2025 Q3	$7.63M	Sell	10,000 -1,000	-9%	-$744K	2.22%	11
2025 Q2	$8.57M	Buy	11,000 +2,000	+22%	+$1.55M	2.33%	15
2025 Q1	$7.43M	Sell	9,000 -6,000	-40%	-$4.99M	4.02%	5
2024 Q4	$11.6M	Buy	15,000 +500	+3%	+$414K	6.1%	2
2024 Q3	$12.8M	Sell	14,500 -500	-3%	-$450K	5.44%	2
2024 Q2	$13.6M	Sell	15,000 -1,000	-6%	-$800K	4.88%	2
2024 Q1	$12.4M	Buy	16,000 +1,000	+7%	+$712K	2.92%	3
2023 Q4	$8.74M	Hold	15,000	–	–	3.65%	7
2023 Q3	$8.06M	Sell	15,000 -2,500	-14%	-$1.29M	4.07%	7
2023 Q2	$8.21M	Sell	17,500 -2,500	-13%	-$1.05M	1.92%	6
2023 Q1	$6.87M	Buy	20,000 +2,500	+14%	+$843K	2.95%	13
2022 Q4	$6.4M	Hold	17,500	–	–	3.01%	13
2022 Q3	$5.66M	Sell	17,500 -4,002	-19%	-$1.27M	3.15%	15
2022 Q2	$6.97M	Buy	21,502 +11,502	+115%	+$3.45M	3.96%	5
2022 Q1	$2.86M	Sell	10,000 -17,500	-64%	-$4.5M	1.18%	40
2021 Q4	$7.6M	Sell	27,500 -7,500	-21%	-$1.9M	3.25%	9
2021 Q3	$8.09M	Sell	35,000 -5,000	-13%	-$1.23M	1.93%	20
2021 Q2	$9.18M	Buy	+40,000	New	+$8.03M	1.79%	12
2021 Q1	–	Sell	-35,000	Closed	-$5.91M	–	54
2020 Q4	$5.91M	Sell	35,000 -20,000	-36%	-$2.99M	2.41%	24
2020 Q3	$8.14M	Buy	+55,000	New	+$8.51M	3.5%	7
2020 Q2	–	Sell	-60,000	Closed	-$4.39M	–	57
2020 Q1	$4.39M	Buy	60,000 +10,000	+20%	+$1.37M	1.73%	27
2019 Q4	$6.57M	Sell	50,000 -5,000	-9%	-$580K	2.44%	18
2019 Q3	$6.15M	Hold	55,000	–	–	3.1%	11
2019 Q2	$6.09M	Sell	55,000 -15,000	-21%	-$1.77M	1.47%	12
2019 Q1	$9.08M	Buy	70,000 +15,000	+27%	+$1.82M	3.35%	2
2018 Q4	$6.37M	Sell	55,000 -15,000	-21%	-$1.68M	3.43%	8
2018 Q3	$7.51M	Sell	70,000 -10,000	-13%	-$1,000K	2.68%	10
2018 Q2	$6.83M	Buy	+80,000	New	+$6.57M	2.62%	10
2017 Q2	–	Sell	-80,000	Closed	-$6.73M	–	70
2017 Q1	$6.73M	Buy	80,000 +50,000	+167%	+$4M	3.13%	7
2016 Q4	$2.21M	Sell	30,000 -70,000	-70%	-$5.21M	1.05%	37
2016 Q3	$8.03M	Buy	100,000 +50,000	+100%	+$4M	4.05%	1
2016 Q2	$3.94M	Buy	+50,000	New	+$3.76M	1.96%	21
2016 Q1	–	Sell	-40,000	Closed	-$3.37M	–	63
2015 Q4	$3.37M	Sell	40,000 -20,000	-33%	-$1.66M	1.6%	29
2015 Q3	$5.02M	Buy	+60,000	New	+$5.07M	2.44%	16

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Sivik Global Healthcare's LLY Position: Q2 2026 in Review

Sivik Global Healthcare held its Eli Lilly (LLY) position steady in Q2 2026 at 5,000 shares worth $4.6M. The position accounts for 3.49% of the portfolio, ranked #7.

Sivik Global Healthcare first reported a position in LLY in Q3 2015 and has held it in 37 quarters since. The position peaked at $13.6M in Q2 2024. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Sivik Global Healthcare held 5,000 shares of Eli Lilly worth $4.6M as of Q2 2026.
Sivik Global Healthcare left its Eli Lilly share count unchanged in Q2 2026.
Eli Lilly made up 3.49% of Sivik Global Healthcare's portfolio in Q2 2026, its #7 holding.
Sivik Global Healthcare first reported a position in Eli Lilly in Q3 2015 and has held it in 37 quarters since.
Sivik Global Healthcare's Eli Lilly position peaked at $13.6M in Q2 2024.
1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Sivik Global Healthcare's 13F filing for Q2 2026, filed 20 Jul 2026.